In the opposite way, an increase in TGFBR3 is recognized to hinder tumor growth in lung cancer with the presence of long non-coding RNA ADAM metallopeptidase with thrombospondin type 1 motif, 9 antisense RNA 2 elevation, and miR-223-3p suppression [35]. The gene discussed is TGFBR3; the disease is lung carcinoma.